Ep Wealth Advisors, LLC Cytosorbents Corp Transaction History
Ep Wealth Advisors, LLC
- $11.7 Billion
- Q4 2024
A detailed history of Ep Wealth Advisors, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 28,000 shares of CTSO stock, worth $24,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,000
Previous 28,000
-0.0%
Holding current value
$24,640
Previous $42,000
40.48%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
55Shares Held
15.6MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$2.72 Million0.29% of portfolio
-
Skylands Capital, LLC3MShares$2.64 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.72 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.48 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.2MShares$1.06 Million0.05% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $38.3M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...